Stryker has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis. The addition of Vertos Medical’s differentiated portfolio will strengthen Stryker’s impact in interventional solutions to address chronic pain.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Wolfe starts Zimmer Biomet at Peer Perform, sees $115-$130 fair value
- Wolfe starts Stryker with an Outperform on leading orthopedics portfolio
- Stryker initiated with an Outperform at Wolfe Research
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- Stryker price target raised to $374 from $360 at BTIG